Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities

Go back to Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities
(NASDAQ: PSNL) Delayed: 16.21 -0.12 (0.73%)
Previous Close $16.33    52 Week High
Open $16.46    52 Week Low
Day High $16.58    P/E N/A 
Day Low $16.19    EPS
Volume 1,391,986